Showing results (71-80 of 92) with videos related to
Sort By:
Pageof 10
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 2, 2004
A prospective population-based management program including primary surgery and postoperative risk assessment by means of DNA ploidy and histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with FIGO stage I-II endometrial cancerT Hogberg, M Fredstorp-Lidebring, P Alm, et al.The Journal of Pathology|June 12, 1999
Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implicationsP Rudolph, H Olsson, G Bonatz, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1992
Flow cytometry DNA analysis and prediction of loco-regional recurrences after mastectomy in breast cancerS B Ewers, R Attewell, B Baldetorp, et al.International Journal of Cancer|February 1, 1993
Comparative cytogenetic and DNA flow cytometric analysis of 150 bone and soft-tissue tumorsN Mandahl, B Baldetorp, M Fernö, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1990
Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experienceT A Alvegard, N O Berg, B Baldetorp, et al.Cytometry|January 1, 1992
Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometryB Baldetorp, M Fernö, A Fallenius, et al.Blood|April 15, 1997
Altered expression of the retinoblastoma tumor-suppressor gene in leukemic cell lines inhibits induction of differentiation but not G1-accumulationG Bergh, M Ehinger, T Olofsson, et al.Scientific Reports|March 25, 2016
The fetal thymus has a unique genomic copy number profile resulting from physiological T cell receptor gene rearrangementAnders Valind, C Haikal, M E K Klasson, et al.Journal of the National Cancer Institute|February 26, 1999
Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancerP Rudolph, P Alm, H J Heidebrecht, et al.APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 1, 1994
Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation--a marker of metastasis?P F Choong, M Akerman, H Willén, et al.Pageof 10